Procter & Gamble Health Share Price

₹ 5,000.00

-₹62.50 (-1.23%)

Last updated 23 Oct, 2026, 15:29 IST

NSE: PGHL

Procter & Gamble Health Share Price Today

As of 24 Oct 2026, Procter & Gamble Health share price is ₹5,000.00. The stock opened at ₹5,059.00, compared to its previous close of ₹5,062.50. During today's trading session, Procter & Gamble Health share price moved in the range of ₹4,735.00 to ₹5,077.00, with an average price of ₹4,906.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹4,707.00 and a high of ₹6,975.00. On the performance front, Procter & Gamble Health share price has declined by 3.67% over the last six months and is down 18.00% on a year-on-year basis.

₹4,735.00

1.23% down today

₹5,077.00

1D LOW

1D HIGH

Procter & Gamble Health Stock Insights

Stock Performance

OutperformingBeat Nifty by 3.58 % in last 6 month

Shareholding Pattern

DIIDII increased stake by 10.42%

Shareholding Pattern

FIIFII increased stake by 1.49%

Stock Performance

OutperformingBeat Nifty by 3.58 % in last 6 month

Shareholding Pattern

DIIDII increased stake by 10.42%

Shareholding Pattern

FIIFII increased stake by 1.49%

Volume

18,321

Average traded price

₹4,963.75

Last traded time

03:29:06 23 Oct

Last traded quantity

₹4,012.00₹6,018.00

Circuit Low

Circuit High

₹4,707.00₹6,975.00

52-Week Low

52-Week High

Circuit

₹4,012.00

₹6,018.00

52-week

₹4,707.00

₹6,975.00

Mkt Cap Cr

8,410.33

P/E

23.41

P/B

15.93

ROA

42.42%

ROE

62.32%

ROCE

84.14%

Quick Ratio

1.65

EV/EBITDA

15.98

Mkt Cap Cr

8,410.33

P/E

23.41

P/B

15.93

ROA

42.42%

ROE

62.32%

ROCE

84.14%

Quick Ratio

1.65

EV/EBITDA

15.98

Based on fundamentals, this stock's

Performance

Very Poor

P & G Health Ltd has not beaten FD return of 7%

Valuation

Overvalued

P & G Health Ltd appears overvalued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROA	ROE	ROCE	Quick Ratio	EV/EBITDA
Sun Pharmaceutical Industries	4,18,204.09	34.51	5.0	11.19%	13.74%	17.33%	2.31	21.4
Divis Laboratories	2,38,496.97	82.76	14.44	14.6%	15.32%	19.56%	3.5	55.36
Torrent Pharmaceuticals	1,70,480.87	79.08	20.27	4.83%	25.49%	13.85%	0.75	37.79
Zydus Lifesciences	1,12,503.47	24.5	4.15	8.57%	18.59%	17.35%	0.91	15.08
Laurus Labs	1,07,954.38	97.82	20.12	10.38%	16.77%	16.14%	0.68	52.98
Cipla	1,07,438.71	32.19	3.14	7.92%	11.27%	14.95%	2.5	18.24
Dr. Reddy's Laboratories	1,02,206.60	32.11	2.68	5.52%	11.07%	12.54%	1.35	16.39
Mankind Pharma	94,042.11	44.29	5.62	7.36%	11.74%	13.13%	0.74	24.75
Aurobindo Pharma	93,556.45	24.33	2.38	6.34%	9.25%	11.76%	1.15	11.85
Lupin	88,028.32	15.86	3.92	14.47%	23.76%	24.88%	1.42	9.4

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Procter & Gamble Health Company Background

ISIN

INE199A01012

Sector Market Cap

₹ 8,410.33 Cr

Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.

Procter & Gamble Health Financial Highlights

Revenue: Procter & Gamble Health reported revenue of ₹1,425.31 crore in FY26 vs ₹944.52 crore in FY25. It showed an increase of 50.90% on a yearly basis.
Operating Profit: Procter & Gamble Health reported an operating profit of ₹449.86 crore in FY26 vs ₹311.62 crore in FY25. It showed an increase of 44.36% on a year-on-year basis.
Net Profit: Procter & Gamble Health reported a net profit of ₹326.91 crore in FY26 vs ₹234.41 crore in FY25. It showed an increase of 39.46% on a yearly basis.

Procter & Gamble Health Quarterly Result Highlights

Procter & Gamble Health reported revenue of ₹367.59 crore in Jun 2026, compared with ₹374.45 crore in Mar 2026, representing a decrease of 1.83% on a quarter-on-quarter (QoQ) basis.
Procter & Gamble Health reported an operating profit of ₹129.12 crore in Jun 2026, compared with ₹133.21 crore in Mar 2026, representing a decrease of 3.07% on a quarter-on-quarter (QoQ) basis.
Procter & Gamble Health reported a profit of ₹96.15 crore in Jun 2026, compared with ₹94.60 crore in Mar 2026, reflecting an increase of 1.64% on a QoQ basis.
The earnings per share (EPS) of Procter & Gamble Health stood at ₹141.00 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more

Promoters

51.82%

FII

6.42%

Other DII

3.74%

Retail and other

29.13%

Mutual funds

8.89%

Foreign Institutional Investor (FII)

FII shareholding by period
Dec 2025	6.97%
Mar 2026	6.20%
Jun 2026	6.33%
Sep 2026	6.42%

1 day

-0.94%

1 week

-2.60%

1 month

-8.02%

1 year

-18.00%

3 years

+0.14%

5 years

-7.50%

Day

Open / Close

Change %

23 Oct 26

₹5,059.00 / ₹5,015.00

-0.94%

22 Oct 26

₹5,015.00 / ₹5,062.50

+0.29%

21 Oct 26

₹5,135.50 / ₹5,048.00

-1.70%

19 Oct 26

₹5,204.50 / ₹5,135.50

-1.24%

Procter & Gamble Health Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Jun 2024	Jun 2023	Jun 2022
Revenue	₹934.17	₹1,151.26	₹1,229.62	₹1,114.41
Other Income	₹10.35	₹15.63	₹18.39	₹13.19
Total Revenue	₹944.52	₹1,166.89	₹1,248.01	₹1,127.60
Total Expenses	₹632.90	₹873.38	₹933.81	₹874.23
Profit Before Tax	₹311.62	₹273.32	₹314.20	₹253.37
Tax	₹77.21	₹72.34	₹84.73	₹60.85
Profit After Tax	₹234.41	₹200.98	₹229.47	₹192.52
EPS - Basic	₹141.00	₹121.00	₹138.00	₹116.00
EPS - Diluted	₹141.00	₹121.00	₹138.00	₹116.00

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Jun 2024	Jun 2023
Profit before tax	₹449.86	₹311.62	₹273.32	₹314.20
Income before WC changes	₹465.04	₹323.82	₹325.59	₹355.69
Change in Assets	-₹73.84	-₹69.92	₹70.57	-₹97.15
Change in Liabilities	₹50.44	-₹3.89	-₹82.68	₹67.13
Change in WC	-₹23.40	-₹73.81	-₹12.11	-₹30.02
Cash flow from Operations	₹337.79	₹168.69	₹228.29	₹236.01
Cash flow from Investing	₹1.26	₹9.59	-₹6.87	-₹21.50
Cash flow from Financing	-₹343.92	-₹234.74	-₹418.11	-₹98.49
Total Cash Flow	-₹4.87	-₹56.46	-₹196.69	₹116.02
Cash (Start of the year)	₹182.27	₹238.73	₹435.42	₹319.40
Cash (End of the year)	₹177.40	₹182.27	₹238.73	₹435.42

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Jun 2024	Jun 2023	Jun 2022
Non-Current Assets	₹267.81	₹270.14	₹305.09	₹280.08
Current Assets	₹526.39	₹524.22	₹796.10	₹608.04
Total Assets	₹794.20	₹794.36	₹1,101.19	₹888.12
Current Liabilities	₹215.31	₹218.91	₹303.90	₹231.90
Net Current Asset	₹311.08	₹305.31	₹492.20	₹376.14
Non-Current Liabilities	₹41.93	₹37.21	₹46.40	₹39.73
Equity Capital	₹536.96	₹538.24	₹750.89	₹616.49
Total Equity & Liabilities	₹794.20	₹794.36	₹1,101.19	₹888.12